Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Cancer Res. 2020 Jan 7;80(5):1102–1117. doi: 10.1158/0008-5472.CAN-19-2374

Figure 1. GM-CSF from IRISOE cells recruits TAMs.

Figure 1.

(A) Representative antibody array of indicated CM (n=3/each). (B) HIF-1α expression in indicated cells and conditions. (C) GM-CSF ELISA in CM of indicated cells conditions (n=3, in triplicates). (D) Level of p-p65/NF-κB in indicated cells and treatments. (E) GM-CSF ELISA of indicated cells and treatments (n=3, in triplicates. (F-L) Migration in Boyden chambers of indicated THP1s towards CM of indicated cells ± GM-CSF NeuAb (n=3, in triplicates). Scale bar=250μm (F), =50μm (G-L). (M) quantification of data in F-L. (N) Expression of CSF2R in indicated cells. (O) A schematic representation of the data presented above.